Infective Endocarditis: Systemic Inflammatory Response in Preoperative Heart Failure

Keywords: inflammatory markers, C-reactive protein, procalcitonin, cardiac surgery, sepsis

Abstract

Surgical outcomes depend on several factors, including the choice of surgical procedure, surgical techniques and experience of medical center. Numerous nationwide population-based studies in Europe have shown an increase in the incidence of infective endocarditis (IE) by 4% per year. An important role in predicting the severity of the disease is played by the systemic inflammatory response, which is manifested by increased levels of inflammatory markers such as C-reactive protein and procalcitonin. The use of a complex of several inflammatory markers can potentially improve the analysis of the inflammatory response system and the assessment of treatment dynamics.

The aim. To evaluate the dynamics of systemic inflammatory response markers in patients with IE complicated by acute heart failure undergoing cardiopulmonary bypass surgery.

Materials and methods. The study included clinical data of 72 patients with IE complicated by preoperative acute heart failure (AHF) who underwent cardiac surgery at the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine from 01/01/2019 to 12/30/2022. The diagnosis of IE was established in accordance with the Duke criteria. All the patients were classified as NYHA class IV.

Results. According to the analysis of systemic inflammatory response markers in patients with IE complicated by AHF at the preoperative stage, the leukocyte count was 10.1 × 109/L (8.1; 14.1), while stab cells accounted for 6.0% (4.0; 8.0). Erythrocyte sedimentation rate was elevated – 27.5 mm per hour (17.0; 50.0). The median body temperature on admission was 37.3 °C (37.1; 38.3). In the early postoperative period, there was a sharp increase in the level of procalcitonin to 2.1 ng/mL, as well as increase in C-reactive protein to 69.33 mg/L. At the same time, an increase in lactate level to 2.24 mmol/L was recorded. On the 7th day of the postoperative period, a decrease in the levels of C-reactive protein and procalcitonin was detected – 34.15 mg/L and 0.2 ng/mL, respectively. In contrast, the lactate level increased to 2.43 mmol/L. Evaluation of biochemical markers of inflammation on postoperative day 14 showed a trend towards normalization: C-reactive protein 28.27 mg/L, procalcitonin 0.1 ng/mL, lactate 2.29 mmol/L.

Conclusions. Timely assessment of specific markers of organ dysfunction associated with infectious processes is the basis for diagnosis, risk stratification and ensuring the best treatment outcome. A comprehensive analysis of the levels of biochemical markers of inflammation creates the conditions for choosing a management strategy for patients with IE complicated by AHF.

References

  1. Chen H, Zhan Y, Zhang K, Gao Y, Chen L, Zhan J, et al. The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019. Front Med (Lausanne). 2022;9:774224. https://doi.org/10.3389/fmed.2022.774224
  2. Momtazmanesh S, Saeedi Moghaddam S, Malakan Rad E, Azadnajafabad S, Ebrahimi N, Mohammadi E, et al. Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990-2019. Eur J Prev Cardiol. 2022;29(8):1287-1297. https://doi.org/10.1093/eurjpc/zwab211
  3. Talha KM, Baddour LM, Thornhill MH, Arshad V, Tariq W, Tleyjeh IM, et al. Escalating incidence of infective endocarditis in Europe in the 21st century. Open Heart. 2021;8(2):e001846. https://doi.org/10.1136/openhrt-2021-001846
  4. Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Lam CSP, Lund LH, et al. Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;81(4):413-424. https://doi.org/10.1016/j.jacc.2022.11.023
  5. Pericàs JM, Hernández-Meneses M, Muñoz P, Martínez-Sellés M, Álvarez-Uria A, de Alarcón A, et al.; Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES). Characteristics and Outcome of Acute Heart Failure in Infective Endocarditis: Focus on Cardiogenic Shock. Clin Infect Dis. 2021;73(5):765-774. https://doi.org/10.1093/cid/ciab098
  6. Bohbot Y, Habib G, Laroche C, Stöhr E, Chirouze C, Hernandez-Meneses M, et al.; EORP EURO-ENDO Registry Investigators Group. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry. Eur J Heart Fail. 2022;24(7):1253-1265. https://doi.org/10.1002/ejhf.2525
  7. Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023;44(39):3948-4042. https://doi.org/10.1093/eurheartj/ehad193
  8. Donal E, Tribouilloy C, Sadeghpour A, Laroche C, Tude Rodrigues AC, Pereira Nunes MDC, et al. Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry. Eur Heart J Open. 2023;3(4):oead064. https://doi.org/10.1093/ehjopen/oead064
  9. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al.; EURO-ENDO Investigators. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222-3232. https://doi.org/10.1093/eurheartj/ehz620
  10. Jensen AD, Østergaard L, Petersen JK, Graversen P, Butt JH, Bundgaard H, et al. Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality-a nationwide study. BMC Cardiovasc Disord. 2022;22(1):338. https://doi.org/10.1186/s12872-022-02761-z
  11. Arjomandi Rad A, Zubarevich A, Osswald A, Vardanyan R, Magouliotis DE, Ansaripour A, et al. The Surgical Treatment of Infective Endocarditis: A Comprehensive Review. Diagnostics (Basel). 2024;14(5):464. https://doi.org/10.3390/diagnostics14050464
  12. Kremer J, Jahn J, Klein S, Farag M, Borst T, Karck M. Early versus Delayed Surgery in Patients with Left-Sided Infective Endocarditis and Stroke. J Cardiovasc Dev Dis. 2023;10(8):356. https://doi.org/10.3390/jcdd10080356
  13. Tsai SS, Wu VC, Chan YH, Chen DY, Cheng YT, Hung KC, et al. Early Surgery for Infective Endocarditis Complicated With Neurologic Injury. J Cardiothorac Vasc Anesth. 2024;38(5):1161-1168. https://doi.org/10.1053/j.jvca.2024.02.011
  14. Liu Y, Guan S, Xu H, Zhang N, Huang M, Liu Z. Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis. Front Cardiovasc Med. 2023;10:1175174. https://doi.org/10.3389/fcvm.2023.1175174
  15. Tian T, Wei B, Wang J. Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis. BMC Emerg Med. 2021;21(1):81. https://doi.org/10.1186/s12873-021-00477-5
  16. Gunebakmaz O, Kaya MG, Kaya EG, Ardic I, Yarlioglues M, Dogdu O, et al. Mean platelet volume predicts embolic complications and prognosis in infective endocarditis. Int J Infect Dis. 2010;14(11):e982-e985. https://doi.org/10.1016/j.ijid.2010.05.019
  17. Ris T, Teixeira-Carvalho A, Coelho RMP, Brandao-de-Resende C, Gomes MS, Amaral LR, et al. Inflammatory biomarkers in infective endocarditis: machine learning to predict mortality. Clin Exp Immunol. 2019;196(3):374-382. https://doi.org/10.1111/cei.13266
  18. Song PS, Ahn KT, Jeong JO, Jeon KH, Song YB, Gwon HC, et al.; KAMIR-NIH Investigators. Association of baseline platelet count with all-cause mortality after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2021;10(2):176-183. https://doi.org/10.1177/2048872620925257
  19. Zhu X, Cheang I, Xu F, Gao R, Liao S, Yao W, et al. Long-term prognostic value of inflammatory biomarkers for patients with acute heart failure: Construction of an inflammatory prognostic scoring system. Front Immunol. 2022;13:1005697. https://doi.org/10.3389/fimmu.2022.1005697
  20. Karlsson S, Heikkinen M, Pettilä V, Alila S, Väisänen S, Pulkki K, et al.; Finnsepsis Study Group. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care. 2010;14(6):R205. https://doi.org/10.1186/cc9327
Published
2024-12-27
How to Cite
1.
Koltunova HB, Antomonov MY, Rudenko OV. Infective Endocarditis: Systemic Inflammatory Response in Preoperative Heart Failure. ujcvs [Internet]. 2024Dec.27 [cited 2025Jan.8];32(4):102-9. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/692

Most read articles by the same author(s)